Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01041326 | Preoperative Radiation Therapy for High Risk Prostate Cancer | completed | Phase 1 | 15 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT00030277 | High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer | completed | Phase 1 | 20 | Focus SurgeryINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00030290 |
| Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate |
| completed |
| Phase 1 |
| — |
| Focus SurgeryINDUSTRY |
| 1 |
| Jul 10, 2013 |
| clinicaltrials |
| NCT00003378 | Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer | terminated | Phase 1 | 45 | Gynecologic Oncology GroupNETWORK | 2 | Jul 9, 2013 | clinicaltrials |
| NCT00006235 | Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 0 | Jul 9, 2013 | clinicaltrials |
| NCT01304745 | Rehabilitation of Women Following Treatment for Gynaecological Cancer; a Randomized, Controlled Study | unknown | Phase 1 | 130 | Haukeland University HospitalOTHER | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT01351688 | An Open Label Prostate Cancer Study in Japanese Patients | completed | Phase 1 | 13 | AstraZenecaINDUSTRY | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00002559 | Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin | completed | Phase 1 / Phase 2 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00004082 | Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors | completed | Phase 1 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00006078 | Lycopene In Preventing of Prostate Cancer | completed | Phase 1 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00055614 | Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 | 20 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00093561 | Lycopene in Preventing Prostate Cancer in Healthy Participants | completed | Phase 1 | — | University of Illinois at ChicagoOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00098995 | Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | completed | Phase 1 | 22 | Peter MacCallum Cancer Centre, AustraliaOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00416325 | Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer | completed | Phase 1 | 18 | University of Illinois at ChicagoOTHER | 0 | Jun 26, 2013 | clinicaltrials |
| NCT00002480 | Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002637 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003394 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | completed | Phase 1 / Phase 2 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00025194 | Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019916 | Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00004928 | Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005634 | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00006041 | Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00006380 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00021034 | Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00003380 | Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | terminated | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00003382 | Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer | terminated | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 10, 2013 | clinicaltrials |
| NCT00058435 | Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00028535 | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00017017 | CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00061867 | Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | ImunonINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00003379 | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer | completed | Phase 1 / Phase 2 | 40 | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00003385 | Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 1 | 48 | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00003967 | Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 1 | 24 | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00005026 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | completed | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00005046 | Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer | completed | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00099008 | Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women | completed | Phase 1 | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00691977 | Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate | withdrawn | Phase 1 | 0 | Virginia Commonwealth UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00756847 | Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors | completed | Phase 1 | 52 | SanofiINDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00842452 | Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 26 | Steven Waggoner, MDOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00039299 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00060372 | Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00036933 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00004211 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 17 | Duke UniversityOTHER | 1 | Mar 21, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 17, 2013source: clinicaltrials